Ying-bei Chen, Ph.D. - Publications

2004 Johns Hopkins University, Baltimore, MD 
Cell Biology, Clergy Religion, Genetics

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Gopalan A, Leversha MA, Dudas ME, Maschino AC, Chang J, Al-Ahmadie HA, Chen YB, Tickoo SK, Reuter VE, Fine SW. TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry. Histopathology. 63: 279-86. PMID 23701505 DOI: 10.1111/his.12153  0.52
2013 Hakimi AA, Ostrovnaya I, Reva B, Schultz N, Chen YB, Gonen M, Liu H, Takeda S, Voss MH, Tickoo SK, Reuter VE, Russo P, Cheng EH, Sander C, Motzer RJ, et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3259-67. PMID 23620406 DOI: 10.1158/1078-0432.CCR-12-3886  0.52
2013 He W, Cheville JC, Sadow PM, Gopalan A, Fine SW, Al-Ahmadie HA, Chen YB, Oliva E, Russo P, Reuter VE, Tickoo SK. Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1355-64. PMID 23599151 DOI: 10.1038/modpathol.2013.72  0.52
2013 Hakimi AA, Chen YB, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, et al. Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. European Urology. 63: 848-54. PMID 23036577 DOI: 10.1016/j.eururo.2012.09.005  0.52
2012 Hardwick JM, Chen YB, Jonas EA. Multipolar functions of BCL-2 proteins link energetics to apoptosis. Trends in Cell Biology. 22: 318-28. PMID 22560661 DOI: 10.1016/j.tcb.2012.03.005  0.52
2012 Ofengeim D, Chen YB, Miyawaki T, Li H, Sacchetti S, Flannery RJ, Alavian KN, Pontarelli F, Roelofs BA, Hickman JA, Hardwick JM, Zukin RS, Jonas EA. N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death. Nature Neuroscience. 15: 574-80. PMID 22366758 DOI: 10.1038/nn.3054  0.52
2011 Chen YB, Aon MA, Hsu YT, Soane L, Teng X, McCaffery JM, Cheng WC, Qi B, Li H, Alavian KN, Dayhoff-Brannigan M, Zou S, Pineda FJ, O'Rourke B, Ko YH, et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. The Journal of Cell Biology. 195: 263-76. PMID 21987637 DOI: 10.1083/jcb.201108059  0.52
2011 Chen YB, Fine SW, Epstein JI. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy. The American Journal of Surgical Pathology. 35: 1054-61. PMID 21606823 DOI: 10.1097/PAS.0b013e318218df97  0.52
2011 Przybycin CG, Cronin AM, Darvishian F, Gopalan A, Al-Ahmadie HA, Fine SW, Chen YB, Bernstein M, Russo P, Reuter VE, Tickoo SK. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution. The American Journal of Surgical Pathology. 35: 962-70. PMID 21602658 DOI: 10.1097/PAS.0b013e31821a455d  0.52
2011 Al-Ahmadie HA, Iyer G, Janakiraman M, Lin O, Heguy A, Tickoo SK, Fine SW, Gopalan A, Chen YB, Balar A, Riches J, Bochner B, Dalbagni G, Bajorin DF, Reuter VE, et al. Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma. The Journal of Pathology. 224: 270-9. PMID 21547910 DOI: 10.1002/path.2892  0.52
2010 Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, Han B, Cao Q, Cao X, Suleman K, Kumar-Sinha C, Dhanasekaran SM, Chen YB, Esgueva R, Banerjee S, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nature Medicine. 16: 793-8. PMID 20526349 DOI: 10.1038/nm.2166  0.52
2010 Wang LT, Tai CJ, Wu YC, Chen YB, Lee FL, Wang SL. Pseudomonas taiwanensis sp. nov., isolated from soil. International Journal of Systematic and Evolutionary Microbiology. 60: 2094-8. PMID 19854877 DOI: 10.1099/ijs.0.014779-0  0.52
2009 Berman SB, Chen YB, Qi B, McCaffery JM, Rucker EB, Goebbels S, Nave KA, Arnold BA, Jonas EA, Pineda FJ, Hardwick JM. Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. The Journal of Cell Biology. 184: 707-19. PMID 19255249 DOI: 10.1083/jcb.200809060  0.52
2007 Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, Bottinger E, Friedman S, Waxman S, Llovet JM. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology (Baltimore, Md.). 45: 938-47. PMID 17393520 DOI: 10.1002/hep.21622  0.52
2005 Zhang J, Chen YB, Hardwick JM, Miller MI, Plachez C, Richards LJ, Yarowsky P, van Zijl P, Mori S. Magnetic resonance diffusion tensor microimaging reveals a role for Bcl-x in brain development and homeostasis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 1881-8. PMID 15728827 DOI: 10.1523/JNEUROSCI.4129-04.2005  0.52
2004 Seo SY, Chen YB, Ivanovska I, Ranger AM, Hong SJ, Dawson VL, Korsmeyer SJ, Bellows DS, Fannjiang Y, Hardwick JM. BAD is a pro-survival factor prior to activation of its pro-apoptotic function. The Journal of Biological Chemistry. 279: 42240-9. PMID 15231831 DOI: 10.1074/jbc.M406775200  0.52
2003 Irusta PM, Chen YB, Hardwick JM. Viral modulators of cell death provide new links to old pathways. Current Opinion in Cell Biology. 15: 700-5. PMID 14644194  0.52
Show low-probability matches.